Novavax Inc. logo

Novavax Inc. (NVAX)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
10. 12
+0.75
+8.0043%
$
1.51B Market Cap
- P/E Ratio
- Div Yield
10.02M Volume
-4.28 Eps
$ 9.37
Previous Close
Add Transaction
Day Range
9.19 10.26
Year Range
6.2 11.97
Want to track NVAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Novavax Inc. (NVAX) Statistics

Valuation metrics

Market Cap 1.51B
Enterprise value 1.63B
Trailing P/E (ttm) -6.09
Forward P/E -17.08
PEG ratio 0.07
Price/Sales (ttm) 3.68
Price/Book (mrq) -7.99
Enterprise Value/Revenue 3.93
Enterprise Value/EBITDA -8.03

Overview

Shares outstanding 164.42M
Float 141.47M
Shares short 49.48M
% Held by insiders 0.05%
% Held by institutions 0.7%
Average volume (10 days) 4.2M
Average volume (90 days) 3.43M

Price summary

52-Week low 6.2
52-Week high 11.97
Beta 2.37
50-Day moving average 7.93
200-Day moving average 9.02

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 10 May 2019

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -0.6%
Operating margin -0.55%

Operational effectiveness

Return on assets -0.26%
Return on equity 1.6%

Income Statement

Revenue (ttm) 596.34M
Revenue per share (ttm) 2.51
Quarterly revenue growth (yoy) -0.79%
Gross profit (ttm) 163.96M
EBITDA 618.89M
Net income to common (ttm) -87.83M
Diluted EPS (ttm) -1.51
Quarterly earnings growth (yoy) -0.78%

Balance Sheet

Total cash (mrq) 790.33M
Total cash per share (mrq) 4.37
Total debt (mrq) 295.06M
Total Debt/Equity (mrq) -1.55
Current ratio (mrq) 2.33%
Book value per share (mrq) -1.16

Cash Flow

Cash flow statement -91.56M
Levered free cash flow (LFCF) 58.57M